Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elif Hindié

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Risk of Overusing Sentinel Node Biopsy in Patients With Thin MelanomaElif Hindié
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA MelanomaElif Hindié
Lancet (London, England)|July 20, 2024
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancerElif Hindié
Theranostics|April 25, 2017
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine TumorsElif Hindié
The New England Journal of Medicine|November 2, 2022
Teclistamab in Relapsed or Refractory Multiple MyelomaElif Hindié
The Lancet. Oncology|September 1, 2023
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategyElif Hindié
The New England Journal of Medicine|June 4, 2020
Ribociclib plus Fulvestrant in Advanced Breast CancerElif Hindié
Lancet (London, England)|January 20, 2020
Optimising first-line treatment for metastatic renal cell carcinomaElif Hindié
Lancet (London, England)|August 21, 2022
Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?Elif Hindié
The New England Journal of Medicine|August 24, 2022
Circulating Tumor DNA Guiding Adjuvant Therapy in Colon CancerElif Hindié
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Risk of Overusing Sentinel Node Biopsy in Patients With Thin MelanomaElif Hindié
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA MelanomaElif Hindié
Lancet (London, England)|July 20, 2024
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancerElif Hindié
Theranostics|April 25, 2017
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine TumorsElif Hindié
The New England Journal of Medicine|November 2, 2022
Teclistamab in Relapsed or Refractory Multiple MyelomaElif Hindié
The Lancet. Oncology|September 1, 2023
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategyElif Hindié
The New England Journal of Medicine|June 4, 2020
Ribociclib plus Fulvestrant in Advanced Breast CancerElif Hindié
Lancet (London, England)|January 20, 2020
Optimising first-line treatment for metastatic renal cell carcinomaElif Hindié
Lancet (London, England)|August 21, 2022
Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?Elif Hindié
The New England Journal of Medicine|August 24, 2022
Circulating Tumor DNA Guiding Adjuvant Therapy in Colon CancerElif Hindié
Pageof 20